No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
紫サツマイモ飲料の摂取がヒト血清肝機能マーカーに及ぼす効果を評価したランダム化二重盲検プラセボ対照群間並行試験の再解析
Rent:
Rent this article for
JPY
Abstract
Objectives This studyʼs objective was to examine the effects of a purple sweet potato(PSP) beverage rich in acylated anthocyanins on serum hepatic biomarkers in healthy Japanese men. Methods We previously published the results of a clinical study on this PSP beverage. In this secondary analysis, we re -examined the previous results of subjects with serum hepatic biomarker levels below the“reference value for which examination is recommended”, which is described in the“Standard Medical Checkup╱Insurance Guidance Program [Revised Version]” published by the Ministry of Health, Labour and Welfare. Results The PSP group had significantly lower GOT values than the placebo group at 2 and 4 weeks after ingestion(P=0.014 and 0.013, respectively). In addition, the PSP group had significantly lower GPT values than the placebo group at 4 weeks after ingestion(P=0.019), and significantly lower γ-GTP values than the placebo group at 2, 6, and 8 weeks after ingestion(P=0.039, 0.025, and 0.002, respectively). Conclusions These results are consistent with those in the previous report, and showed that the PSP beverage improved liver function in healthy men with serum hepatic biomarker levels below the“reference value for which examination is recommended”.
Full text loading...
/content/article/0386-3603/46030/411